Research programme: autoimmune disease therapeutics - Sigma-tau

Drug Profile

Research programme: autoimmune disease therapeutics - Sigma-tau

Alternative Names: Contragestazol; DL 111; DL-111-IT; ST 1959

Latest Information Update: 29 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator sigma-tau SpA
  • Class Abortifacients; Triazoles
  • Mechanism of Action Androgen receptor modulators; Cyclin modulators; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Autoimmune disorders; Cancer

Most Recent Events

  • 06 Mar 2007 Preclinical trials in Autoimmune disorders in Italy (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top